Pubblicazioni

Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice

2023 - EUROPEAN THYROID JOURNAL

Capdevila, Jaume; Deandreis, Desireeâ; Durante, Cosimo; Leboulleux, Sophie; Luster, Markus; Netea-Maier, Romana; Newbold, Kate; Singer, Susanne; P Sykiotis, Gerasimos; Bartes, Beate; Farnell, Kate; Deborah Locati, Laura

Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer: Treatment Optimization for Maximum Clinical Benefit

2022 - THE ONCOLOGIST

Wirth, Lori J; Durante, Cosimo; Topliss, Duncan J; Winquist, Eric; Robenshtok, Eyal; Iwasaki, Hiroyuki; Luster, Markus; Elisei, Rossella; Leboulleux, Sophie; Tahara, Makoto

Predictors of response and survival to multikinase inhibitors in radioiodine resistant differentiated thyroid cancer

2021 - JOURNAL OF PERSONALIZED MEDICINE

Feola, T.; Cozzolino, A.; Centello, R.; Pandozzi, C.; Tarsitano, M. G.; Giannetta, E.